Insoluble ionic complexes of polyacrylic acid with a cationic drug for use as a mucoadhesive, ophthalmic drug delivery system.
We have developed a new mucoadhesive drug delivery formulation based on an ionic complex of partially neutralized poly(acrylic acid) (PAA) and a highly potent beta blocker drug, levobetaxolol x hydrochloride (LB x HCl), for use in the treatment of glaucoma. PAA was neutralized with sodium hydroxide to varying degrees of neutralization. Aqueous solutions containing concentrations of LB x HCl equivalent to the degree of PAA neutralization were added to the PAA solutions and formed insoluble complexes, which were isolated. The complex formation was followed by turbidimetric titration, and the complexes were characterized by IR and 1H NMR spectroscopy. Complexes were prepared with varying degrees of drug loading, such that the same PAA chain would have free -COOH groups for mucoadhesion along with ionic complexes of LB x H+ with COO- groups. Thin films of the complexes dissociated to release the drug by ion exchange with synthetic tear fluid. The films shrunk continuously during release of the drug and dissolved completely in 1 h. Solid inserts of these films could be useful as a mucoadhesive ophthalmic drug delivery system.
Lele
B S
BS
Bioengineering Department, University of Washington, Seattle 98195, USA.
Hoffman
A S
AS
D000180:Acrylic Resins / Q000008:administration & dosage* / Q000737:chemistry; D015784:Betaxolol / Q000008:administration & dosage* / Q000737:chemistry; D002412:Cations; D016503:Drug Delivery Systems / Q000379:methods*; D009682:Magnetic Resonance Spectroscopy; D008422:Materials Testing / Q000379:methods; D009391:Nephelometry and Turbidimetry; D009883:Ophthalmic Solutions / Q000008:administration & dosage*; D017550:Spectroscopy, Fourier Transform Infrared; D013666:Tears
D000180:Acrylic Resins; D002412:Cations; D009883:Ophthalmic Solutions; C006903:carbopol 940; D015784:Betaxolol